'CRISPR-Gold' fixes Duchenne muscular dystrophy mutation in mice

(University of California - Berkeley) Scientists at the University of California, Berkeley, have engineered a new way to deliver CRISPR-Cas9 gene-editing technology inside cells and have demonstrated in mice that the technology can repair the mutation that causes Duchenne muscular dystrophy, a severe muscle-wasting disease.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news